Results 41 to 50 of about 11,879,963 (351)

Potential Anticancer Activity of Auranofin

open access: yesChemical and Pharmaceutical Bulletin, 2019
Gold compounds have a long history of use in medicine. Auranofin was developed more than 30 years ago as an oral therapy for rheumatoid arthritis. Now, however, auranofin is rarely used in clinical practice despite its efficacy for treating rheumatoid arthritis because more novel antirheumatic medications are available.
Isao, Momose   +2 more
openaire   +5 more sources

Anticancer Activity of the Antibiotic Clioquinol [PDF]

open access: yesCancer Research, 2005
AbstractClioquinol, a metal chelator, has been used for many years as an antimicrobial agent and more recently as a potential treatment for Alzheimer's disease. Because it binds copper and zinc, metals essential for the activity of the enzyme superoxide dismutase-1 (SOD1), a potential target for anticancer drug development, we investigated its effects ...
Wei-Qun, Ding   +4 more
openaire   +2 more sources

The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells

open access: yesMolecules, 2020
The link between the antimicrobial and anticancer activity of peptides has long been studied, and the number of peptides identified with both activities has recently increased considerably. In this work, we hypothesized that designed peptides with a wide
Davor Juretić   +6 more
doaj   +1 more source

Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53 independent pathways [PDF]

open access: yes, 2014
Most cancer cells use aerobic glycolysis to fuel their growth. The enzyme lactate dehydrogenase-A (LDH-A) is key to cancer’s glycolytic phenotype, catalysing the regeneration of nicotinamide adenine dinucleotide (NAD þ ) from reduced nicotinamide adenine
Allison, Simon J.   +6 more
core   +1 more source

Anticancer Activity of Cynomorium coccineum [PDF]

open access: yesCancers, 2018
The extensive applications of Cynomorium species and their rich bioactive secondary metabolites have inspired many pharmacological investigations. Previous research has been conducted to examine the biological activities and numerous interesting pharmaceutical activities have been reported. However, the antitumor activities of these species are unclear.
Mouna Sdiri   +6 more
openaire   +3 more sources

Developing Strategy for a Successful Antioxidant, Anticancer Activity via an Improved Method Prepared to Porous Silicon Nanoparticles [PDF]

open access: yesJournal of Applied Sciences and Nanotechnology, 2021
Porous silicon nanoparticles, or PSNPs, are one of the most common NPS with distinct characteristics. PSNPs were created using an enhanced approach known as the electrochemical etching process.
Kareem Jawad, Butheina Hasson
doaj   +1 more source

Anticancer efficacy of phenolics based structurally related compounds and their radical scavenging action [PDF]

open access: yes, 2011
Cancer, one of the leading causes of death worldwide, is an abnormal cell proliferation that fails to respond to the normal signals. In an effort to eradicate the growing menace of cancer, a clear understanding of fundamental biology and molecular ...
Arvind S. Negi   +3 more
core   +2 more sources

Anticancer Activity of Papaver Somniferum

open access: yesJournal of the Turkish Chemical Society, Section A: Chemistry, 2016
This work describes the pharmacological activity of extracts of Papaver somniferum, a poppy species. P. somniferum products are still considered as a unique source of drug for many diseases.
Döne Aslı Güler   +3 more
doaj   +1 more source

Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer

open access: yesBiomolecules, 2021
Cancer, a fatal disease, is also one of the main causes of death worldwide. Despite various developments to prevent and treat cancer, the side effects of anticancer drugs remain a major concern.
Jurnal Reang   +3 more
doaj   +1 more source

Inhibiting RRM2 to enhance the anticancer activity of chemotherapy.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients.
Yaqiong Zhan   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy